These innovative treatments , including Semaglutide , belong to a class of drugs called GLP-1 agents. Originally developed for treating type 2 diabetes , they function by assisting the pancreas to produce adequate the hormone insulin and limiting high blood sugar levels. Furthermore , their capacity to encourage weight management has led to increas